Mantle Cell Lymphoma (MCL) Unknown Status Phase 1 / 2 Trials for Bendamustine (DB06769)

Back to Mantle Cell Lymphoma (MCL)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

Indication	Status	Phase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))	Unknown Status	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01221103	Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)	Treatment	Bendamustine (DB06769) Dexamethasone (DB01234) Ofatumumab (DB06650)